1. The effects of oxprenolol on ambulatory intra-arterial blood pressure in essential hypertension

   • M. W. Millar-Craig
   • S. Mann
   • E. B. Raftery

   Originals Pages: 713 - 721

2. Local blood flow regulation in normotensive man during prolonged treatment with propranolol

   • K. Jensen
   • K. Skagen
   • E. Kjøller

   Originals Pages: 723 - 726

3. Metabolism of propranolol in the human maternal-placental-foetal unit

   • M. T. Smith
   • I. Livingstone
   • E. J. Triggs

   Originals Pages: 727 - 732

4. Effect of nitroglycerin ointment (Nitrong^®) on exercise tolerance and several circulatory parameters in patients with angina pectoris

   • G. Nyberg
   • V. Panfilov

   Originals Pages: 733 - 739

5. Time course of the bronchial response to salbutamol after placebo, betaxolol and propranolol

   • R. Palminteri
   • G. Kaik

   Originals Pages: 741 - 745

6. Sulphinpyrazone and renal function following myocardial infarction

   • S. L. Choudhury
   • S. H. Taylor
   • D. B. Morgan

   Originals Pages: 747 - 750

7. Streptokinase and anisoylated streptokinase plasminogen complex

   • D. H. Staniforth
   • R. A. G. Smith
   • M. Hibbs

   Originals Pages: 751 - 756

8. Renal effects of aminophylline in hepatic cirrhosis

   • L. Milani
   • C. Merkel
   • A. Gatta

   Originals Pages: 757 - 760

9. Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained release tablet

   • M. Lagas
   • J. H. G. Jonkman

   Originals Pages: 761 - 767

10. Inhibition of postprandial colonic motility by sulpiride in patients with irritable colon

    • G. A. Lanfranchi
    • G. Bazzocchi
    • C. Brignola

    Originals Pages: 769 - 772

11. A phenylbutazone dose-finding study in rheumatoid arthritis

    • H. A. Bird
    • P. A. Leatham
    • V. Wright

    Originals Pages: 773 - 776

12. Aspirin pharmacokinetics in migraine. The effect of metoclopramide

    • L. M. Ross-Lee
    • M. J. Eadie
    • J. H. Tyrer

    Originals Pages: 777 - 785

13. Biotransformation of furosemide in kidney transplant patients

    • D. E. Smith
    • L. Z. Benet

    Originals Pages: 787 - 790

14. Bioavailability of two preparations of furosemide and their pharmacological activity in normal volunteers

    • H. Ogata
    • S. Zugarni
    • Y. Kawatsu

    Originals Pages: 791 - 796

15. Contribution of the genetic status of oxidative metabolism to variability in the plasma concentrations of beta-adrenoceptor blocking agents

    • P. Dayer
    • L. Balant
    • J. Fabre

    Originals Pages: 797 - 799

16. Pharmacokinetics in man of acebutolol and hydrochlorothiazide as single agents and in combination

    • A. Roux
    • A. Le Liboux
    • B. Flouvat

    Originals Pages: 801 - 806

17. Erythrocyte Na⁺, K⁺-ATPase and serum digoxin concentrations

    • A. H. L. From
    • G. J. Quarfoth
    • K. Ahmed

    Originals Pages: 807 - 812

18. The pharmacokinetics of subcutaneous dihydroergotamine with and without a dextran 70 infusion

    • B. Lindblad
    • E. Abisch
    • D. Bergqvist

    Originals Pages: 813 - 818

19. Chloramphenicol pharmacokinetics in Ethiopian children of differing nutritional status

    • M. Eriksson
    • L. Paalzow
    • T. W. Mariam

    Originals Pages: 819 - 823

20. The binding of ketamine to plasma proteins: Emphasis on human plasma

    • P. G. Dayton
    • R. L. Stiller
    • J. M. Perel

    Originals Pages: 825 - 831

21. The design of a study of the drug etiology of agranulocytosis and aplastic anemia

    • S. Shapiro

    Report Pages: 833 - 836

22. Steady state disposition of chloroquine in patients with rheumatoid disease

    • M. Frisk-Holmberg
    • Y. Bergqvist
    • B. Domeij-Nyberg

    Short Communication Pages: 837 - 839

23. Announcements

    Announcement Pages: 840 - 840